XLOXilio Therapeutics, Inc.同业对比
Xilio Therapeutics, Inc. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XLO本股 | $46M#7 | — | 0.6x#5 | 1.1x#1 | 589.9%#2 | 39.8%#4 | -95.9%#2 | -48.5%#4 | — | — | -28.5%#3 | — |
| CLNN | $50M#1 | — | — | 250.2x#6 | -41.5%#5 | 33.6%#5 | -11541.5%#6 | — | — | — | -68.8%#5 | — |
| HOWL | $49M#2 | — | 3.0x#9 | — | — | 13.7%#7 | — | -373.3%#11 | -229.9%#4 | — | -22.2%#2 | — |
| HYPD | $49M#3 | — | 0.5x#2 | 60.4x#5 | 1318.8%#1 | 9.0%#10 | -5743.5%#5 | -44.5%#3 | -46.8%#2 | — | — | — |
| SKYE | $47M#4 | — | — | — | — | -110.5%#13 | — | — | — | — | -89.3%#9 | — |
| ATNM | $47M#5 | 4.3x#2 | 1.5x#8 | 520.5x#7 | — | 11.4%#9 | -40274.4%#7 | -111.8%#9 | — | — | 4.9%#1 | — |
| CTOR | $47M#6 | — | 1.2x#6 | — | — | -17.1%#11 | — | -61.3%#6 | — | — | -70.3%#6 | — |
| AZTR | $46M#8 | 37.7x#4 | 6.2x#13 | — | -100.0%#7 | -22.2%#12 | — | -149.4%#10 | — | — | -85.9%#7 | — |
| BMEA | $45M#9 | — | 3.7x#10 | — | — | 55.4%#2 | — | -509.2%#13 | — | — | -54.5%#4 | — |
| APUS | $4M#15 | — | 0.0x#1 | — | — | -331.7%#15 | — | -5.6%#1 | -11.2%#1 | — | -86.6%#8 | — |
| ELTX | $44M#10 | — | 5.6x#12 | 19.3x#4 | -91.9%#6 | 23.8%#6 | -1639.0%#4 | -498.6%#12 | — | — | — | — |
| DWTX | $42M#11 | 0.7x#1 | 0.6x#4 | — | — | -177.4%#14 | — | -50.1%#5 | — | — | — | — |
| SCYX | $37M#12 | 13.4x#3 | 0.6x#3 | 1.8x#2 | 449.9%#3 | 59.6%#1 | -78.0%#1 | -12.9%#2 | — | 7#1 | — | — |
| VERU | $37M#13 | — | 1.3x#7 | 2.2x#3 | 3.6%#4 | 39.9%#3 | -146.6%#3 | -80.1%#7 | -399.3%#5 | — | — | 0.0%#1 |
| NNVC | $35M#14 | — | 4.0x#11 | — | — | 13.2%#8 | — | -94.7%#8 | -78.2%#3 | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-03。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议